Code of Federal Regulations · Subpart
Subpart A — General Labeling Provisions
21 C.F.R. pt. 201, subpt. A
- § 201.1 Drugs; Name And Place Of Business Of Manufacturer, Packer, Or Distributor
- § 201.2 Drugs And Devices; National Drug Code Numbers
- § 201.5 Drugs; Adequate Directions For Use
- § 201.6 Drugs; Misleading Statements
- § 201.10 Drugs; Statement Of Ingredients
- § 201.15 Drugs; Prominence Of Required Label Statements
- § 201.16 Drugs; Spanish-language Version Of Certain Required Statements
- § 201.17 Drugs; Location Of Expiration Date
- § 201.18 Drugs; Significance Of Control Numbers
- § 201.19 Drugs; Use Of Term “infant”
- § 201.20 Declaration Of Presence Of Fd&c Yellow No. 5 And/or Fd&c Yellow No. 6 In Certain Drugs For Human Use
- § 201.21 Declaration Of Presence Of Phenylalanine As A Component Of Aspartame In Over-the-counter And Prescription Drugs For Human Use
- § 201.22 Prescription Drugs Containing Sulfites; Required Warning Statements
- § 201.23 Required Pediatric Studies
- § 201.24 Labeling For Systemic Antibacterial Drug Products
- § 201.25 Bar Code Label Requirements
- § 201.26 Exceptions Or Alternatives To Labeling Requirements For Human Drug Products Held By The Strategic National Stockpile